Additional information
| Active substance | Atomoxetine |
|---|---|
| Formula | C17H21NO |
| Side effects | Dry mouth, insomnia, decreased appetite, increased blood pressure and heart rate |
| Effects | Improves attention, reduces impulsivity and hyperactivity in ADHD |
| Dosage (sports) | Not applicable as it is not used for enhancing athletic performance |
| Dosage (medical) | Typically starts at 40 mg per day for adults, adjusted as needed |
| Half-life | Approximately 5 hours |
| Main action | Increases norepinephrine and dopamine levels in the prefrontal cortex |
| Substance class | Selective norepinephrine reuptake inhibitor |
| Chemical name | N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Strattera |
| Blood pressure | Can cause an increase in blood pressure and heart rate |
| WAREHOUSE | International Warehouse 2 |
| Also known as | Tomoxetine |
| Lab Test | Not specifically monitored through lab tests, focus is on clinical assessment |
| Hepatotoxicity | Rare, but potential severe liver injury |
| Water Retention | None |
| Use in sports | None, as it is not anabolic or performance-enhancing |
| Manufacturer | Lilly |
Reviews
There are no reviews yet.